Skip to navigation Skip to content

Featured Links: >

ESPAÑOL
Newly Diagnosed
Ask an MS Expert
MS Navigator
Walk MS
Bike MS
Ways to Give

Menu

Navigation

National Multiple Sclerosis Society

Sign In

Searchv

What is MS?
Symptoms & Diagnosis
Treating MS
Resources & Support
Living Well with MS
Research
Get Involved

d What is MS?
d Symptoms & Diagnosis
d Treating MS
d Resources & Support
d Living Well with MS
d Research
d Get Involved
d Ways to Donate
- d Other Ways to Donate
d About the Society
d Helpful Links
d For Professionals
d Magazine & Blog
d Our Healthcare Voice
d Multiple Sclerosis and COVID-19
- d COVID-19 Vaccine Guidance for People Living with MS
- d Disease Modifying Therapy Guidance During COVID-19

Home Research Participate in Research Studies Participate in a Clinical Trial Clinical Trial: Ozanimod to Improve Cognitive Function

Share this page

Facebook Twitter Email

Clinical Trial: Ozanimod to Improve Cognitive Function

Return to search

Participate in a Clinical Trial

MS Trial Alerts
Clinical Trial FAQs
Clinical Trial Resources
Placebo Response

Share

Smaller Text
Larger Text
Print

Details

Type of MS: RRMS|SPMS
Number of Subjects: 250
Medication: ozanimod (Zeposia®, Bristol Myers Squibb)
Location: Alabama|California|Colorado|District of Columbia|Florida|Georgia|Illinois|Indiana|Iowa|Kansas|Louisiana|Michigan|Minnesota|Missouri|Montana|New Jersey|New York|North Dakota|Ohio|Pennsylvania|Tennessee|Texas|Virginia|Washington|West Virginia|Wisconsin

Institutions: Multicenter, nationwide Contact Information
1-888-260-1599
clinicaltrialdisclosure@celgene.com

Funding:

Celgene

Description

Investigators are recruiting 250 people with relapsing forms of MS for a clinical trial to determine if ozanimod (Zeposia^®, Bristol Myers Squibb) improves cognitive functions, specifically information processing speed. The study is funded by Celgene.

Read more

Share

Smaller Text
Larger Text
Print

Colophon

Stay Informed

Join Us

Facebook Twitter Instagram LinkedIn YouTube

About the Society
Helpful Links
For Professionals

What is MS?
Symptoms & Diagnosis
Treating MS
Resources & Support
Living Well with MS
Research
Get Involved
Magazine & Blog
Program Calendar
Careers

© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.

We use cookies to provide an enhanced experience, to keep our site safe and to deliver specific messaging. By accepting, you consent to the use of all cookies and by declining, only essential cookies will be used to make our website work. More details can be found in our Privacy Policy.